16 results
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
12 Feb 24
Additional proxy soliciting materials
12:39pm
of the Company’s previously disclosed workforce reduction plan and focus on exploring strategic alternatives, based upon the Staff’s belief that the Company
8-K
BLPH
Bellerophon Therapeutics, Inc.
24 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that in light of the Company’s previously disclosed workforce reduction plan
8-K
2oum18m4k
29 Jun 23
Cost Associated with Exit or Disposal Activities
4:06pm
- Prev
- 1
- Next